Cystic fibrosis causes complications across nearly every organ system, not just the lungs. While progressive lung damage is the most well-known and life-threatening complication, CF also affects the pancreas, liver, intestines, reproductive organs, and mental health. For children born today with CF, median predicted survival has reached age 65, which means managing these complications over a full lifespan matters more than ever.
Chronic Lung Damage and Bronchiectasis
The most serious complication of cystic fibrosis is progressive lung destruction. The defective CFTR protein causes airways to produce thick, sticky mucus that traps bacteria and triggers relentless inflammation. Immune cells, mainly neutrophils and macrophages, flood the airways trying to fight infection but release enzymes and reactive oxygen molecules that break down the lung tissue itself. Over time, this creates a vicious cycle: infection fuels inflammation, inflammation damages the airway walls, and the damaged airways become even more prone to infection.
This cycle leads to bronchiectasis, a permanent widening and scarring of the airways. Once bronchiectasis develops, the lungs can no longer clear mucus effectively, and lung function declines with each new infection. Certain bacteria, particularly species of Pseudomonas and nontuberculous mycobacteria, are especially damaging and accelerate lung function loss once they become established. Lung disease remains the leading cause of death in people with CF.
Cystic Fibrosis-Related Diabetes
Diabetes is one of the most common complications as people with CF get older. Thick mucus gradually damages the pancreas, destroying the cells that produce insulin. This form of diabetes, called CFRD, is distinct from both type 1 and type 2. It shares features of each but requires its own management approach.
The numbers climb steeply with age: about 2% of children with CF have diabetes, rising to 19% of adolescents, 40% of people in their twenties, and 45 to 50% of those over 30. CFRD can silently worsen lung function and nutritional status before it’s caught, which is why annual screening typically begins in adolescence. Most people with CFRD need insulin, since the underlying problem is that the pancreas can no longer make enough of it.
Pancreatic Insufficiency and Malabsorption
Nearly all people with CF develop pancreatic insufficiency, meaning the pancreas cannot release enough digestive enzymes into the small intestine. Without these enzymes, the body struggles to break down and absorb fats, fat-soluble vitamins (A, D, E, and K), and proteins. The result is greasy, foul-smelling stools, poor weight gain, and nutritional deficiencies that compound the energy demands of fighting chronic lung infections.
Pancreatic enzyme replacement taken with every meal and snack restores normal or near-normal absorption for most people. Getting the dose right is an ongoing process, especially during growth spurts, pregnancy, or periods of illness. Without adequate enzyme replacement, malnutrition becomes a serious risk factor for faster lung decline.
Intestinal Obstruction
A complication unique to CF is distal intestinal obstruction syndrome, or DIOS. Thick intestinal secretions combine with poorly digested food to form a mass that blocks the junction between the small and large intestine. Symptoms come on suddenly: sharp abdominal pain, bloating, vomiting, and a firm, palpable lump in the lower right abdomen.
DIOS is different from ordinary constipation, which also occurs frequently in CF. Constipation develops gradually and involves stool spread throughout the colon. DIOS strikes acutely, with the blockage concentrated in one spot. The distinction matters because treatment is different. DIOS often requires specialized laxative solutions to dissolve the mass, and severe cases can need hospital-based treatment.
Liver Disease
The same thick secretions that damage the lungs and pancreas can block the bile ducts in the liver. Over time, this leads to inflammation, scarring, and fatty liver changes. A large review of CF registry data found that about 3.6% of people with CF develop cirrhosis, the most advanced stage of liver scarring. A smaller number progress to portal hypertension, where pressure builds in the blood vessels around the liver, raising the risk of internal bleeding.
Liver disease in CF often develops silently during childhood and adolescence. Routine monitoring with blood tests and imaging helps catch it early, before significant damage accumulates.
Excessive Salt Loss
The CFTR protein normally controls the movement of salt and water across cell surfaces, including sweat glands. In CF, sweat contains two to four times the normal concentration of sodium and chloride. This is actually the basis for the sweat test used to diagnose CF, but it also creates a real clinical risk. During hot weather, exercise, or fever, people with CF can lose dangerous amounts of salt through sweat, potentially leading to dangerously low sodium levels and, in extreme cases, cardiovascular collapse. Extra salt intake and careful hydration are everyday considerations, not just during illness.
Male Infertility
Between 97 and 98% of men with CF are infertile. The cause is structural: the vas deferens, the tube that carries sperm from the testicle, never develops. This condition, called congenital bilateral absence of the vas deferens, means sperm are produced normally but have no way to reach the ejaculate. Men with CF can still become biological fathers through sperm retrieval procedures combined with assisted reproduction. This is a physical issue, not a hormonal one, so testosterone levels and sexual function are unaffected.
Women with CF can conceive naturally, though thicker cervical mucus may reduce fertility somewhat. Pregnancy is increasingly common as survival improves, but it requires careful coordination between CF and obstetric care teams.
Depression and Anxiety
Living with a demanding chronic illness takes a measurable toll on mental health. A meta-analysis pooling data from thousands of people with CF found depression rates of about 19% in adolescents and 27% in adults. Anxiety rates were even higher: 26% in adolescents and 28% in adults. These rates are roughly two to three times what you’d see in the general population.
Depression and anxiety aren’t just quality-of-life concerns in CF. They’re linked to worse adherence to treatment regimens, poorer lung function, and more frequent hospitalizations. Mental health screening is now a recommended part of routine CF care for anyone over age 12, recognizing that treating the psychological burden is inseparable from treating the physical disease.